Health Care

Navigating the complexities of an industry in transition

  • Share

Pervasive challenges in the health care industry have prompted profound transformation in how health care is accessed, delivered and financed. These changes are opening opportunities for hospitals, health insurers and other health care-focused organizations to rethink strategies — and find innovations in lowering costs while delivering exceptional value.

 As you navigate complexities and pursue opportunities on the industry's new horizon, we can help you grow and thrive.

EY - Shaping your telehealth strategy teaser

Shaping your telehealth strategy

Learn how the health care industry is leveraging telehealth technologies to lower costs, improve quality outcomes and enhance the patient experience.

EY Strategic Growth Forum 2013

Health care reform: early adopters share lessons learned

Panel members who have taken the lead in responding to the Affordable Care Act, discuss the risks, costs, compliance and strategic obligations of health care reform.

EY- New-horizons-2013-August-23-2013

New Horizons: 2013 health care provider report

Innovations in the US health care industry proliferate, but systems for delivering and paying for care haven’t kept pace. How are these challenges being addressed?

EY- Managed-Care-2-0-everything-old-is-new-again

Managed Care 2.0: everything old is new again?

The Affordable Care Act signaled a new era in US health care. Our report highlights key differences between managed care of the 1990s and today.

EY- Image for Let's Talk promo

Let's talk: optimization, growth, protecting performance

In an increasingly complex environment, organizations are looking for new ways to optimize, grow, and protect their business.

Health Industry Post: population health management

Health Industry Post: population health management

Population health management principles and technologies have the potential to curtail costs and deliver value. Learn how payers and providers are collaborating for positive outcomes.

New Horizons: 2012 health care provider report

New Horizons: 2012 health care provider report

As the health care industry moves from rewarding volume to rewarding quality outcomes, collaboration is a vital approach. We provide key considerations for executives and board members.

Five things you ought to know about ICD-10

Five things you ought to know about ICD-10

ICD-10 will multiply and alter the codes US providers and payers use for coding medical information. Our 5: insights for executives series explores five key questions for evaluating ICD-10 readiness.

Health Care Advisory Services

Health Care Advisory Services

Our integrated health care practice leverages payer and provider perspectives – providing a holistic view of the health care landscape. Learn more.

Health Care Industry Post library

Health Care Industry Post library

Access our archive of news and analysis of key issues in the health care industry.

Health insurance exchanges are coming

US health care reform

Health care reform law has vast implications for all companies and their employees, as well as hospitals, health plans, pharmaceutical companies and other industry stakeholders.

Health insurance exchanges are coming

Many states have begun developing health insurance exchanges. Find out how to be a leader and increase membership, market share and growth.

Access more of our health care reform resources. 

Access more of our ACA tax resources

Tax implications of the Affordable Care Act

For employers, the Affordable Care Act (ACA) is more than a benefits law. It's a tax law that has far-reaching impact on US companies of all industries, geographies and sizes.

Access more of our ACA tax resources

 

Beyond Borders: global biotech report 2013

Life sciences industry reports

Covering the areas of biotech, pharma and medical technology, our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

Beyond Borders: global biotech report 2013

We saw a strong performance by major biotech players, but a challenging environment for the rest of the industry. Read more in our 2013 industry report.

Access more of our Life Sciences resources.